UICC World Cancer Congress 2006

Methods: A state-wide population based survey of men aged 40 and above (BRFSS, 2001-2, WA state) and a probability sample of primary care physicians, conducted in the same geographic area. Targeted screening definition was PSA or DRE within past year. .

Results: Age-related screening included 32% at ages 50-64, 56% at ages 65-80, 67%, and over age 80, 71%. Adjusted analyses indicated that age, household income, possessing health insurance and a personal doctor were all positively associated with screening status. In the physician survey most physicians recommend DRE and PSA to their average risk male patients. Three-fourths (74%) of physicians discussed benefits and risks of prostate cancer screening with their patients; but few regularly used educational tools. Only 35% discussed the side effects of prostate cancer treatment with their patients.

Conclusions: The majority of physicians discuss prostate cancer screening with their patients, with few decision-making tools are used. All relevant information may not be provided in the discussion. These results point to the need for increasing informed decision making about prostate cancer screening.